All In MedTech

FDA Clearance Tracker · P070008-S036

STRATOS LV/LV-T, EVIA AND ENTOVIS HF/HF-T CRT-P'S

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 18, 2013 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 18, 2013

Approved

Time to decision

90 days

Received Dec 18, 2012. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P070008-S036
Device name
STRATOS LV/LV-T, EVIA AND ENTOVIS HF/HF-T CRT-P'S
Applicant location
Lake Oswego, OR
Received
Dec 18, 2012
Decided
Mar 18, 2013
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P070008

Device type

Device class
Class III

Every decision under product code NKE

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE ILESTO 7/5 VR-T ICD, ILESTO 7/5 VR-T DX ICD, ILESTO 7/5 DR-T ICD, ILESTO 7/5 HFT CRT-D; IFORIA 7/5 VR-T ICD, IFORIA 7/5 VR-T DX ICD, IFORIA 7/5 DR-T ICD, IFORIA 7/5 HF-T CRT-D; AND THE PSW 1205.U.

Source documents

Other decisions for Biotronik, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.